The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

The aim of this study was to evaluate the effects of calcium-vitamin D and metformin on the menstrual cycle and ovulation in patients with polycystic ovary syndrome (PCOS).

Who Took Part

The study group was 60 patients.

The age groups tagged for this paper are young adults and adults, women only.

In this pilot study, 60 infertile PCOS patients were enrolled in a randomized clinical trial and divided into three equal groups.

Regularity of menses, number of large follicles (> or = 14 mm) and pregnancy rates were compared among the three groups.

How the Study Was Run

The researchers set it up as a randomized and pilot study.

The patients were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

What Was Measured

Topics PubMed links to this paper include Calcium, Hypoglycemic Agents, Infertility, Female, Menstrual Cycle, Metformin, Ovulation and Pilot Projects.

What This Means in Plain Language

The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc in 60 patients.

Results are reported in around 2 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2009 (Taiwanese journal of obstetrics & gynecology), a journal based in China (Republic : 1949- ).

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.